The Food and Drug management (Food And Drug Administration) recently authorized a brand new medication to treat low sexual drive in females.
But exactly how precisely does the medication work, and why is it not the same as the other medicine available on the market?
The medication, called bremelanotide (name brand Vyleesi) is authorized to deal with premenopausal females with hypoactive desire that is sexual (HSDD), an ailment for which low sexual interest causes individual stress, the Food And Drug Administration stated in a declaration. It really is just the 2nd FDA-approved medication for HSDD in women.
Ladies self-administer the injection beneath the skin regarding the stomach or thigh at the least 45 moments before expected activity that is sexual. Ladies must not just simply take one or more dosage of bremelanotide within a period that is 24-hour significantly more than eight doses each month. 5 Myths About Women’s Bodies
In research of greater than 1,200 premenopausal females with HSDD, 25% of these whom took bremelanotide saw some improvements within their reported desire that is sexual, weighed against 17% whom took a placebo.
Bremelanotide binds to receptors into the brain called melanocortin receptors, which are likely involved in several biological functions, such as for example kcalorie burning and diet, skin pigmentation and discomfort legislation. Read More